Beam Therapeutics Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Beam Therapeutics Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2020 to Q3 2024.
  • Beam Therapeutics Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $9.84M, a 19.2% decline year-over-year.
  • Beam Therapeutics Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $40.5M, a 52.7% decline year-over-year.
  • Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2023 was $45.3M, a 42.1% decline from 2022.
  • Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2022 was $78.3M, a 259% increase from 2021.
  • Beam Therapeutics Inc. annual Nonoperating Income (Expense) for 2021 was $21.8M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $40.5M $9.84M -$2.34M -19.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $42.8M $13.9M -$5.49M -28.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $48.3M $5.46M +$3M +121% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $45.3M $11.3M -$40.3M -78.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $85.7M $12.2M +$2.54M +26.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $83.1M $19.4M +$9.36M +93.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $73.8M $2.47M -$4.54M -64.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $78.3M $51.6M +$52.9M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $25.4M $9.64M -$31.9M -76.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $57.3M $10M +$27.3M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $30M $7.01M +$8.2M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $21.8M -$1.22M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $41.5M +$38.6M +1347% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$17.3M -$9.35M -118% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$1.19M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 $2.87M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$7.93M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.